AIMM Therapeutics BV

8:30 AM - 8:45 AM (JST), Wednesday, March 6, 2019 ・ 2nd Floor
AIMM is a preclinical stage company in the process of advancing 2 antibodies into the clinic.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Netherlands
Year Founded:
2004
Main Therapeutic Focus:
Lead Product in Development:
AT1412
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided